Holen Sie sich die Stockscreener-App
2.02
21.69%
0.36
Handel nachbörslich:
2.01
-0.01
-0.50%
Schlusskurs vom Vortag:
$1.66
Offen:
$2.07
24-Stunden-Volumen:
27.52M
Relative Volume:
1.58
Marktkapitalisierung:
$255.81M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-112.46M
KGV:
-1.2317
EPS:
-1.64
Netto-Cashflow:
$-99.89M
1W Leistung:
-3.35%
1M Leistung:
-19.20%
6M Leistung:
+51.88%
1J Leistung:
+143.31%
1-Tages-Spanne:
$1.95
$2.30
1-Wochen-Bereich:
$1.62
$2.30
52-Wochen-Spanne:
$0.1311
$3.29
Vor Biopharma Inc Stock (VOR) Company Profile
Firmenname
Vor Biopharma Inc
Sektor
Branche
Telefon
617-655-6580
Adresse
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Vergleichen Sie VOR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
2.02 | 248.67M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | Eingeleitet | Wedbush | Outperform |
| 2022-04-27 | Eingeleitet | Goldman | Neutral |
| 2021-12-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-12-02 | Eingeleitet | Oppenheimer | Outperform |
| 2021-10-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-03-25 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-03-03 | Eingeleitet | Evercore ISI | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Sell |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
Alle ansehen
Vor Biopharma Inc Aktie (VOR) Neueste Nachrichten
Vor Biopharma: Chinese Win Sets The Direction, But There Is Still Much Uncertainty - Seeking Alpha
Vor Bio Rallies On Strong Data For Autoimmune Drug Candidate - Benzinga
Is Vor Bio Stock Soaring Too High? - StocksToTrade
Vor Bio, RemeGen succeed in trial for telitacicept in China - Seeking Alpha
Vor Biopharma Shares Jump After Phase 3 Telitacicept Study Achieves Primary Endpoint - MarketScreener
Surge in Vor Bio Stock: What’s Driving It? - timothysykes.com
Breakthrough for Sjögren's Disease: Vor Bio's Drug Shows Best-in-Disease Potential in Phase 3 - Stock Titan
Vor Biopharma Soars 9.04% on Bullish Analyst Forecast - AInvest
Vor Biopharma's High-Stakes Gamble: Can Telitacicept Justify the Burn? - AInvest
Borrow Rate Hikes Hit Vor Biopharma, Upexi, and Defiance 1.75x MSTR ETF Amid Market Volatility - AInvest
Is Vor Biopharma Inc. a strong growth stockBest Picks for Fast Turnaround - news-j.co.kr
Vor Biopharma VOR 2025Q2 Earnings Preview Upside Ahead on New Navigational Systems Integration - AInvest
Vor Biopharma Inc. (NASDAQ:VOR) Short Interest Update - MarketBeat
Vor Biopharma Inc expected to post a loss of 44 cents a shareEarnings Preview - TradingView
Intraday Charts Show Spike in Vor Biopharma Inc. ActivitySwing Trade Plans Emphasize Risk Management - metal.it
Vor Bio appoints seasoned biotech executive Dallan Murray as Chief Commercial Officer - MarketScreener
Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer - GlobeNewswire
Vor Bio Taps Commercial Powerhouse Behind Sarepta's $1.8B Revenue Surge for Global Drug Launch - Stock Titan
What are Vor Biopharma Inc. company’s key revenue driversDynamic investment opportunities - Jammu Links News
How volatile is Vor Biopharma Inc. stock compared to the marketBuild a portfolio with strong long-term growth - Jammu Links News
What institutional investors are buying Vor Biopharma Inc. stockAchieve breakthrough investment performance - Jammu Links News
Why is Vor Biopharma Inc. stock attracting strong analyst attentionBuild wealth faster with expert stock picks - Jammu Links News
What catalysts could drive Vor Biopharma Inc. stock higher in 2025Navigate market volatility with smart strategies - Jammu Links News
What drives Vor Biopharma Inc. stock priceInvest smarter with expert trading signals - Jammu Links News
How does Vor Biopharma Inc. generate profit in a changing economyHigh-impact stock picks - Jammu Links News
What analysts say about Vor Biopharma Inc. stockRapid-fire capital growth - Jammu Links News
What makes Vor Biopharma Inc. stock price move sharplyCapitalize on market momentum for maximum gains - Jammu Links News
Is Vor Biopharma Inc. stock overvalued or undervaluedSignificant capital appreciation - Jammu Links News
How many analysts rate Vor Biopharma Inc. as a “Buy”Capitalize on fast-moving trading opportunities - Jammu Links News
What are the technical indicators suggesting about Vor Biopharma Inc.Rapid wealth creation - Jammu Links News
VOR SEC FilingsVor Biopharma Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Why Vor Biopharma Inc. stock attracts strong analyst attentionSwing Trading Plan With Smart Signals in Review - metal.it
Insiders the biggest winners as Vor Biopharma Inc.'s (NASDAQ:VOR) market cap rises to US$302m - simplywall.st
When is Vor Biopharma Inc. stock expected to show significant growth - jammulinksnews.com
Vor Biopharma (VOR) Jumps 10% on Addition of 2 CEOs to Board - MSN
These 10 Stocks are Winning Big - Insider Monkey
Vor Biopharma Shares Soar After Strategic Appointments in Leadership - StocksToTrade
Published on: 2025-07-28 13:58:09 - metal.it
What are analysts’ price targets for Vor Biopharma Inc. in the next 12 monthsGet timely alerts on market opportunities - Jammu Links News
Should I hold or sell Vor Biopharma Inc. stock in 2025Achieve breakthrough financial results - jammulinksnews.com
Does Vor Biopharma Inc. stock perform well during market downturnsMaximize your portfolio’s growth potential - Jammu Links News
What markets is Vor Biopharma Inc. expanding into Is DMAC stock a good long term investment option - jammulinksnews.com
What are the latest earnings results for Vor Biopharma Inc.Unlock real-time stock alerts for quick profits - Jammu Links News
How Efficient Is Vor Biopharma Inc. at Controlling Operating CostsDefensive Stock Picks with Upside - metal.it
Published on: 2025-07-27 20:45:01 - jammulinksnews.com
Finanzdaten der Vor Biopharma Inc-Aktie (VOR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):